After An Embattled Year, Dendreon Has A New CEO
Make a commentBy Ed Silverman // February 1st, 2012 // 9:15 am
• Pharma Blog » Archives
Provenge
And The Outlook For Provenge Is… A Mixed Bag
Make a commentBy Ed Silverman // January 9th, 2012 // 10:22 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // January 5th, 2012 // 8:10 am
Who Is The Worst Biotech CEO? Can You Guess?
5 CommentsBy Ed Silverman // December 9th, 2011 // 8:15 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // November 3rd, 2011 // 7:05 am
A Bristol Skin Cancer Med & Unsustainable Cost
6 CommentsBy Ed Silverman // October 14th, 2011 // 9:49 am
Reversal Of Fortune? A J&J Pill And Provenge
5 CommentsBy Ed Silverman // October 10th, 2011 // 8:15 am
The Cost Of Treating Cancer Is ‘Unsustainable’
9 CommentsBy Ed Silverman // September 26th, 2011 // 12:17 pm
The Dendreon Bloodletting: 500 Jobs & COO To Go
2 CommentsBy Ed Silverman // September 8th, 2011 // 3:35 pm